Combined lactic acidosis and ketoacidosis in a female diabetic patient with severe heart failure.
Nzomessi D, Massie E, Gariani K, Giraud R, Meyer P.
Cardiovasc Endocrinol Metab. 2023 Jul 4;12(3):e0287. doi: 10.1097/XCE.0000000000000287. eCollection 2023 Sep.
Severe lactic acidosis with euglycemic diabetic ketoacidosis due to metformin overdose.
Kuno H, Fujimaru T, Kadota N, Konishi K, Sekiguchi M, Watanabe K, Ito Y, Nagahama M, Taki F, Hifumi T, Otani N, Nakayama M.
CEN Case Rep. 2023 Nov;12(4):408-412. doi: 10.1007/s13730-023-00783-w. Epub 2023 Mar 19.
Severe euglycemic diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor: case report and literature review.
El Ess MS, ElRishi MA.
Ann Med Surg (Lond). 2023 Apr 11;85(5):2097-2101. doi: 10.1097/MS9.0000000000000479. eCollection 2023 May.
Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period.
Menghoum N, Oriot P, Hermans MP.
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102275. doi: 10.1016/j.dsx.2021.102275. Epub 2021 Sep 15.
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond.
Sciacqua A, Succurro E, Armentaro G, Miceli S, Pastori D, Rengo G, Sesti G.
Heart Fail Rev. 2023 May;28(3):667-681. doi: 10.1007/s10741-021-10182-x. Epub 2021 Dec 2.
Euglycemic Ketoacidosis and Lactic Acidosis Associated With Metformin Toxicity.
Al-Moussally F, Tien JJ, Rajagopalan K, Boterosuarez C, Crouse R.
Cureus. 2024 May 20;16(5):e60661. doi: 10.7759/cureus.60661. eCollection 2024 May.
Metformin and lactic acidosis in diabetic humans.
Lalau JD, Race JM.
Diabetes Obes Metab. 2000 Jun;2(3):131-7. doi: 10.1046/j.1463-1326.2000.00053.x.
SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes.
Donnan K, Segar L.
Eur J Pharmacol. 2019 Mar 5;846:23-29. doi: 10.1016/j.ejphar.2019.01.002. Epub 2019 Jan 11.
Non-occlusive Mesenteric Ischemia with Diabetic Ketoacidosis and Lactic Acidosis Following the Administration of a Sodium Glucose Co-transporter 2 Inhibitor.
Gocho N, Aoki E, Okada C, Omura K, Hirashima T, Suzuki N, Tanaka H, Omori Y.
Intern Med. 2016;55(13):1755-60. doi: 10.2169/internalmedicine.55.6338. Epub 2016 Jul 1.
Acute Metabolic Complications in Diabetes.
Rewers A.
In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 17.
